<DOC>
	<DOCNO>NCT00798694</DOCNO>
	<brief_summary>The purpose research study determine whether one glaucoma eye drop less likely cause change surface eye ( conjunctiva ) another . The investigator plan determine theory compare result patient use two different prostaglandin , Xalatan Travatan Z . ( Both drop presently market approve FDA treatment eye pressure ) . Because study mask , clinician review study result know study drop patient use .</brief_summary>
	<brief_title>How Similar Are Changes Surface Eye When Two Different Glaucoma Eye Drops Are Used ?</brief_title>
	<detailed_description>Two group enter study : group 1 naive treatment group 2 use Xalatan least one month . Both group use one drop bedtime Xalatan right eye one drop bedtime Travatan Z leave eye .</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<mesh_term>Travoprost</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Age 21 old Able understand protocol agree 3 visit Any type glaucoma SLT , ALT , PI accept Naïve : No prior glaucoma treatment ( medical surgical ) If pt noncompliant , must meds 3 month Xalatan : At least one month use Both Groups : Any history ocular surface disease Dry eye syndrome prior Restasis use Prior ocular surgery cataract extraction Uveitis inflammatory disease eye adnexa Systemic medication might influence ocular inflammation Any active inflammation infection Pregnancy intention become pregnant Naïve : Prior use topical glaucoma med unless 3 month . Use preserve artificial tear preparation last 30 day one year history chronic use Xalatan : Prior use Travatan Travatan Z</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>glaucoma</keyword>
	<keyword>impression cytology</keyword>
	<keyword>ocular surface change</keyword>
	<keyword>prostaglandin</keyword>
</DOC>